NO20053211D0 - Forbindelser for behandling av metabolske forstyrrelser. - Google Patents

Forbindelser for behandling av metabolske forstyrrelser.

Info

Publication number: NO20053211D0
Authority: NO; Norway
Prior art keywords: compounds; treatment; metabolic disorders; metabolic; disorders
Prior art date: 2003-02-13

Application number

NO20053211A

Other languages

English (en)

Other versions

NO20053211L (no

NO334606B1 (no

Inventor

Reid W Von Borstel

Shalini Sharma

Kirvin L Hodge

Albert Lee

Original Assignee

Wellstat Therapeutics Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-13

Filing date

2005-06-30

Publication date

2005-06-30

2005-06-30 Application filed by Wellstat Therapeutics Corp filed Critical Wellstat Therapeutics Corp

2005-06-30 Publication of NO20053211D0 publication Critical patent/NO20053211D0/no

2005-10-20 Publication of NO20053211L publication Critical patent/NO20053211L/no

2014-04-22 Publication of NO334606B1 publication Critical patent/NO334606B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20053211A 2003-02-13 2005-06-30 Forbindelser, farmasøytiske preparater inneholdende slike samt slike forbindelser og preparater for behandling av metabolske forstyrrelser NO334606B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US44716803P	2003-02-13	2003-02-13
PCT/US2004/003718 WO2004073611A2 (en)	2003-02-13	2004-02-09	Compounds for the treatment of metabolic disorders

Publications (3)

Publication Number	Publication Date
NO20053211D0 true NO20053211D0 (no)	2005-06-30
NO20053211L NO20053211L (no)	2005-10-20
NO334606B1 NO334606B1 (no)	2014-04-22

Family

ID=32908414

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053211A NO334606B1 (no)	2003-02-13	2005-06-30	Forbindelser, farmasøytiske preparater inneholdende slike samt slike forbindelser og preparater for behandling av metabolske forstyrrelser

Country Status (18)

Country	Link
US (3)	US7615575B2 (no)
EP (2)	EP2266946A3 (no)
JP (2)	JP4697962B2 (no)
KR (1)	KR101106631B1 (no)
CN (1)	CN1750758B (no)
AU (2)	AU2004212905B2 (no)
BR (1)	BRPI0407506A (no)
CA (1)	CA2513092C (no)
ES (1)	ES2530235T3 (no)
IL (1)	IL169332A (no)
MX (1)	MXPA05008600A (no)
NO (1)	NO334606B1 (no)
NZ (1)	NZ542072A (no)
PL (1)	PL377712A1 (no)
RU (2)	RU2005128501A (no)
UA (1)	UA81013C2 (no)
WO (1)	WO2004073611A2 (no)
ZA (1)	ZA200504558B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL159320A0 (en) *	2001-06-12	2004-06-01	Wellstat Therapeutics Corp	Compounds for the treatment of metabolic disorders
CA2502297C (en) *	2002-11-01	2011-12-13	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
ES2530235T3 (es) *	2003-02-13	2015-02-27	Wellstat Therapeutics Corporation	Compuestos para el tratamiento de trastornos metabólicos
DE602004030004D1 (de)	2003-04-15	2010-12-23	Wellstat Therapeutics Corp	Verbindungen zur behandlung von stoffwechselstörungen
US7361686B2 (en)	2003-04-22	2008-04-22	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
KR101192272B1 (ko) *	2003-04-30	2012-10-17	웰스태트 테러퓨틱스 코포레이션	대사 질환의 치료용 화합물
UA88772C2 (ru) *	2003-08-20	2009-11-25	Уэллстат Терепьютикс Корпорейшн	Соединения для лечения расстройств метаболизма
WO2006127133A2 (en) *	2005-04-01	2006-11-30	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
UA95613C2 (ru) *	2005-11-09	2011-08-25	Уеллстат Терепьютикс Корпорейшн	Соединения для лечения расстройсв метаболизма
WO2007087504A2 (en)	2006-01-25	2007-08-02	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
NZ569729A (en) *	2006-01-25	2011-07-29	Wellstat Therapeutics Corp	Compounds for the treatment of metabolic disorders
JP2009531280A (ja) *	2006-01-25	2009-09-03	ウェルスタットセラピューティクスコーポレイション	代謝障害を処置するための化合物
WO2007092729A2 (en) *	2006-02-02	2007-08-16	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
JP2009531288A (ja) *	2006-02-13	2009-09-03	ウェルスタットセラピューティクスコーポレイション	代謝障害の処置のための化合物
AU2007220868B2 (en) *	2006-02-28	2011-06-09	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
EP2001461A4 (en) *	2006-03-31	2010-06-09	Wellstat Therapeutics Corp	COMBINATION TREATMENT FOR METABOLISM DISEASES
KR20090010035A (ko) *	2006-05-18	2009-01-28	웰스태트 테러퓨틱스 코포레이션	물질대사 장애의 치료용 화합물
MX2008015640A (es) *	2006-06-09	2009-01-09	Wellstat Therapeutics Corp	Compuestos para el tratamiento de trastornos metabolicos.
JP2010501010A (ja) *	2006-08-17	2010-01-14	ウェルスタットセラピューティクスコーポレイション	代謝障害のための併用処置
FR2917084B1 (fr) *	2007-06-05	2009-07-17	Galderma Res & Dev	Nouveaux derives d'acide 3-phenyl propanoique activateurs des recpteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
JP5496913B2 (ja) *	2008-01-15	2014-05-21	ウェルスタットセラピューティクスコーポレイション	代謝異常の治療のための化合物
NZ587433A (en) *	2008-03-13	2012-12-21	Wellstat Therapeutics Corp	Compounds and method for reducing uric acid
AU2013200226B2 (en) *	2008-03-13	2015-01-15	Wellstat Therapeutics Corporation	Compounds and method for reducing uric acid
CN102573462B (zh) *	2009-10-13	2014-04-16	维尔斯达医疗公司	用于降低尿酸的3位取代的化合物
WO2012033720A1 (en)	2010-09-08	2012-03-15	Wellstat Therapeutics Corporation	Benzoic acid compounds for reducing uric acid
CN102399148B (zh) *	2010-09-14	2014-03-05	中国科学院成都生物研究所	一类降血脂化合物及其制备方法和用途
FR2976943B1 (fr) *	2011-06-23	2013-07-12	Metabolys	Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
MX376872B (es) *	2014-10-10	2025-03-07	Prometic Pharma Smt Ltd	Compuestos aromaticos sustituidos y composiciones farmaceuticas para la prevencion y tratamiento de la diabetes.
US11497723B1 (en) *	2017-12-19	2022-11-15	Tony Antakly	PPAR-gamma activators, HDAC inhibitors and their therapeutical usages
US10702488B2 (en) *	2017-12-19	2020-07-07	Theriac Biomedical Inc.	PPAR-γ activators, HDAC inhibitors and their therapeutical usages
SG11202103011YA (en) *	2018-10-11	2021-04-29	Basf As	Aromatic compounds and pharmaceutical uses thereof

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2100341A (en) *	1934-11-24	1937-11-30	United Shoe Machinery Corp	Shoe bottom coating machine
GB1393854A (en) *	1973-02-26	1975-05-14	Pfizer	Benzoic acid compounds and pharmaceutical compositions containing them
US4098816A (en) *	1973-08-23	1978-07-04	Beecham Group Limited	Polycyclic oxy-aromatic acid
CS181686B2 (en) *	1974-01-14	1978-03-31	Isf Spa	Process for preparing 4-cyclopropylmethylenoxy-3-chlorphenylacetic acid
CS175831B1 (no)	1974-12-17	1977-05-31
GB1561350A (en)	1976-11-05	1980-02-20	May & Baker Ltd	Benzamide derivatives
US4268442A (en)	1978-11-14	1981-05-19	Sagami Chemical Research Center	Process for preparing aromatic acetic acid
DE3575127D1 (de)	1984-02-14	1990-02-08	Hirai Hidefumi	Herstellung substituierter ungesaettigter sechsgliedriger ringverbindungen aus phenolabkoemmlingen.
DE3884825D1 (de)	1987-02-16	1993-11-18	Konishiroku Photo Ind	Entwickler für lichtempfindliche lithographische Druckplatte, gemeinschaftlich verarbeitungsfähig für den Negativ-Typ und den Positiv-Typ und Entwicklerzusammensetzung für lichtempfindliches Material.
JPH0770025B2 (ja)	1987-09-16	1995-07-31	富士通株式会社	薄膜磁気ヘッドの製造方法
US4923501A (en)	1987-11-04	1990-05-08	Kumiai Chemical Industry Co., Ltd.	Pyrimidine derivatives, processes for their production, and herbicidal method and compositions
DE3738406A1 (de) *	1987-11-12	1989-05-24	Henkel Kgaa	Sebosuppressive topische zubereitungen
JPH01216961A (ja)	1988-02-25	1989-08-30	Takeda Chem Ind Ltd	１２−リポキシゲネース阻害剤
GB8806471D0 (en) *	1988-03-18	1988-04-20	Tisdale M J	Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours
US4897397A (en)	1988-12-16	1990-01-30	Schering Corporation	Aryl-alkynoic, alkenoic or alkanoic compounds and compositions useful as antiallergy and anti-inflammatory agents
JPH0348603A (ja)	1989-07-14	1991-03-01	Wakayama Pref Gov	抗菌防臭材料
HUT60458A (en)	1991-02-01	1992-09-28	Sandoz Ag	Process for producing benzyloxyphenyl derivatives and pharmaceutical compositions comprising same
US5589492A (en) *	1992-04-10	1996-12-31	Smithkline Beecham Plc	Heterocyclic compounds and their use in the treatment of Type-II diabetes
KR950703280A (ko)	1992-09-09	1995-09-20	미리암 디.메코너헤이	제초성 벤젠 화합물(Herbicidal Benzene Compounds)
US5484926A (en)	1993-10-07	1996-01-16	Agouron Pharmaceuticals, Inc.	HIV protease inhibitors
JPH06293700A (ja)	1993-04-08	1994-10-21	Nippon Soda Co Ltd	６−クロロサリチル酸の製造法
GB9315595D0 (en)	1993-07-28	1993-09-08	Res Inst Medicine Chem	New compounds
JPH07206658A (ja)	1994-01-12	1995-08-08	Shiseido Co Ltd	尋常性座瘡治療剤
GB9401460D0 (en) *	1994-01-26	1994-03-23	Rhone Poulenc Rorer Ltd	Compositions of matter
JPH08119959A (ja)	1994-10-20	1996-05-14	Oyo Seikagaku Kenkyusho	キサントン誘導体及びこれを有効成分とするモノアミン酸化酵素阻害剤
US5728718A (en)	1994-12-20	1998-03-17	The United States Of America As Represented By The Department Of Health And Human Services	2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
US5530157A (en)	1995-02-16	1996-06-25	Scios Nova Inc.	Anti-inflammatory benzoic acid derivatives
FR2730731B1 (fr)	1995-02-20	1997-04-04	Rhone Poulenc Chimie	Procede de carboxylation d'un ether aromatique
WO1996028423A1 (en)	1995-03-15	1996-09-19	Sankyo Company, Limited	Dipeptide compounds having ahpba structure
JPH08325250A (ja)	1995-05-31	1996-12-10	Sumitomo Metal Ind Ltd	新規置換フェノール誘導体
US5519133A (en)	1995-06-02	1996-05-21	American Cyanamid Co.	3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
US6423704B2 (en)	1995-12-20	2002-07-23	Aventis Pharmaceuticals Inc.	Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en)	1995-12-20	2001-02-27	Aventis Pharmaceuticals Inc.	Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
WO1997025992A1 (en)	1996-01-16	1997-07-24	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
CA2255858C (en)	1996-05-24	2007-09-11	Neurosearch A/S	Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
KR20000065227A (ko)	1996-07-19	2000-11-06	다께다 구니오	복소환 화합물, 그의 제조방법 및 용도
AU725403B2 (en) *	1996-09-13	2000-10-12	Merck & Co., Inc.	Thrombin inhibitors
JPH1087489A (ja)	1996-09-13	1998-04-07	Sankyo Co Ltd	Ａｈｐｂａ構造含有ジペプチド化合物を有効成分とする医薬
JP3981771B2 (ja)	1996-10-19	2007-09-26	株式会社クレハ	２−ベンジルオキシ−６−アルコキシ安息香酸誘導体、その製造方法及び、農園芸用殺菌剤
AU8750298A (en) *	1997-08-28	1999-03-22	Ono Pharmaceutical Co. Ltd.	Peroxisome proliferator-activated receptor controllers
AU732335B2 (en)	1997-09-09	2001-04-12	Merck & Co., Inc.	3-(iodophenoxymethyl) carbapenem antibacterials
DK1031563T3 (da)	1997-09-30	2006-05-08	Daiichi Seiyaku Co	Sulfonylderivater
KR100340273B1 (ko)	1997-10-14	2002-06-14	야마모토 카즈모토	비페닐-5-알칸산 유도체 및 이의 용도
JP2001508811A (ja)	1998-04-20	2001-07-03	藤沢薬品工業株式会社	ｃＧＭＰ−ホスホジエステラーゼ阻害剤としてのアントラニル酸誘導体
JP4154773B2 (ja)	1998-11-13	2008-09-24	住友電気工業株式会社	単結晶製造方法および装置
GB9914371D0 (en)	1999-06-18	1999-08-18	Smithkline Beecham Plc	Novel compounds
CA2325358C (en) *	1999-11-10	2005-08-02	Pfizer Products Inc.	7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino\|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b
US6677473B1 (en)	1999-11-19	2004-01-13	Corvas International Inc	Plasminogen activator inhibitor antagonists
AUPQ570100A0 (en) *	2000-02-17	2000-03-09	Fujisawa Pharmaceutical Co., Ltd.	Beta-alanine derivatives and their use as receptor antagonists
US6632765B1 (en)	2000-06-23	2003-10-14	Chervon U.S.A. Inc.	Catalyst regeneration via reduction with hydrogen
EA005976B1 (ru)	2000-06-28	2005-08-25	Туларик Инк.	Хинолинил и бензотиазолил ppar-гамма модуляторы
EP1300142A4 (en) *	2000-07-05	2004-05-19	Ajinomoto Kk	HYPOGLYCEMIC COMPOUNDS
AR031126A1 (es)	2000-08-29	2003-09-10	Abbott Lab	Acidos amino(oxo)aceticos inhibidores de la proteina tirosina fosfatasa
AR035216A1 (es)	2000-12-01	2004-05-05	Astrazeneca Ab	Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
IL159320A0 (en) *	2001-06-12	2004-06-01	Wellstat Therapeutics Corp	Compounds for the treatment of metabolic disorders
DE10135027A1 (de)	2001-07-18	2003-02-06	Solvay Pharm Gmbh	Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen
AU2003211384B2 (en) *	2002-02-21	2008-12-11	Asahi Kasei Pharma Corporation	Substituted phenylalkanoic acid derivative and use thereof
CA2502297C (en)	2002-11-01	2011-12-13	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
DE10257785A1 (de) *	2002-12-11	2004-07-01	Bayer Healthcare Ag	Isophthalsäurederivate
US7601868B2 (en) *	2003-02-12	2009-10-13	Takeda Pharmaceutical Company Limited	Amine derivative
ES2530235T3 (es) *	2003-02-13	2015-02-27	Wellstat Therapeutics Corporation	Compuestos para el tratamiento de trastornos metabólicos
JP4282345B2 (ja)	2003-03-12	2009-06-17	株式会社日立製作所	半導体集積回路装置
DE602004030004D1 (de) *	2003-04-15	2010-12-23	Wellstat Therapeutics Corp	Verbindungen zur behandlung von stoffwechselstörungen
US7361686B2 (en)	2003-04-22	2008-04-22	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
KR101192272B1 (ko)	2003-04-30	2012-10-17	웰스태트 테러퓨틱스 코포레이션	대사 질환의 치료용 화합물
CN101031539A (zh) *	2003-08-14	2007-09-05	旭化成制药株式会社	取代的芳基链烷酸衍生物及其用途
CA2536089A1 (en)	2003-08-20	2005-03-03	Eli Lilly And Company	Ppar modulators
UA88772C2 (ru) *	2003-08-20	2009-11-25	Уэллстат Терепьютикс Корпорейшн	Соединения для лечения расстройств метаболизма
US7541455B2 (en) *	2003-12-22	2009-06-02	Ventana Medical Systems, Inc.	Microwave mediated synthesis of nucleic acid probes
WO2006127133A2 (en) *	2005-04-01	2006-11-30	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
UA95613C2 (ru) *	2005-11-09	2011-08-25	Уеллстат Терепьютикс Корпорейшн	Соединения для лечения расстройсв метаболизма
WO2007087504A2 (en) *	2006-01-25	2007-08-02	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
JP2009531280A (ja) *	2006-01-25	2009-09-03	ウェルスタットセラピューティクスコーポレイション	代謝障害を処置するための化合物
NZ569729A (en) *	2006-01-25	2011-07-29	Wellstat Therapeutics Corp	Compounds for the treatment of metabolic disorders
WO2007092729A2 (en) *	2006-02-02	2007-08-16	Wellstat Therapeutics Corporation	Compounds for the treatment of metabolic disorders
JP2009531288A (ja) *	2006-02-13	2009-09-03	ウェルスタットセラピューティクスコーポレイション	代謝障害の処置のための化合物
KR20090010035A (ko) *	2006-05-18	2009-01-28	웰스태트 테러퓨틱스 코포레이션	물질대사 장애의 치료용 화합물

2004
- 2004-02-09 ES ES04709467.7T patent/ES2530235T3/es not_active Expired - Lifetime
- 2004-02-09 KR KR1020057014896A patent/KR101106631B1/ko not_active Expired - Fee Related
- 2004-02-09 PL PL377712A patent/PL377712A1/pl unknown
- 2004-02-09 NZ NZ542072A patent/NZ542072A/en not_active IP Right Cessation
- 2004-02-09 WO PCT/US2004/003718 patent/WO2004073611A2/en not_active Ceased
- 2004-02-09 BR BRPI0407506-4A patent/BRPI0407506A/pt not_active Application Discontinuation
- 2004-02-09 EP EP10184293A patent/EP2266946A3/en not_active Withdrawn
- 2004-02-09 CN CN2004800041504A patent/CN1750758B/zh not_active Expired - Fee Related
- 2004-02-09 MX MXPA05008600A patent/MXPA05008600A/es active IP Right Grant
- 2004-02-09 JP JP2005518490A patent/JP4697962B2/ja not_active Expired - Fee Related
- 2004-02-09 EP EP04709467.7A patent/EP1601251B1/en not_active Expired - Lifetime
- 2004-02-09 CA CA2513092A patent/CA2513092C/en not_active Expired - Fee Related
- 2004-02-09 RU RU2005128501/15A patent/RU2005128501A/ru not_active Application Discontinuation
- 2004-02-09 US US10/531,630 patent/US7615575B2/en not_active Expired - Fee Related
- 2004-02-09 AU AU2004212905A patent/AU2004212905B2/en not_active Ceased
- 2004-09-02 UA UAA200508520A patent/UA81013C2/uk unknown
2005
- 2005-06-03 ZA ZA200504558A patent/ZA200504558B/xx unknown
- 2005-06-21 IL IL169332A patent/IL169332A/en not_active IP Right Cessation
- 2005-06-30 NO NO20053211A patent/NO334606B1/no not_active IP Right Cessation
2007
- 2007-08-20 US US11/841,489 patent/US7605181B2/en not_active Expired - Fee Related
2008
- 2008-10-08 AU AU2008229824A patent/AU2008229824A1/en not_active Abandoned
- 2008-12-24 RU RU2008151414/15A patent/RU2521284C2/ru not_active IP Right Cessation
2009
- 2009-07-24 JP JP2009173719A patent/JP2009242434A/ja not_active Withdrawn
- 2009-08-31 US US12/550,482 patent/US7932290B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1601251A2 (en)	2005-12-07
MXPA05008600A (es)	2005-11-04
CN1750758B (zh)	2012-06-20
UA81013C2 (en)	2007-11-26
JP2009242434A (ja)	2009-10-22
HK1079400A1 (en)	2006-04-07
JP4697962B2 (ja)	2011-06-08
EP1601251B1 (en)	2014-11-12
WO2004073611A3 (en)	2004-11-25
KR101106631B1 (ko)	2012-01-20
US7932290B2 (en)	2011-04-26
AU2004212905A1 (en)	2004-09-02
RU2005128501A (ru)	2006-04-27
NO20053211L (no)	2005-10-20
WO2004073611A2 (en)	2004-09-02
AU2004212905B2 (en)	2008-10-09
CA2513092C (en)	2011-11-01
BRPI0407506A (pt)	2006-02-14
US20060247309A1 (en)	2006-11-02
KR20050098924A (ko)	2005-10-12
NZ542072A (en)	2007-11-30
US7615575B2 (en)	2009-11-10
EP2266946A2 (en)	2010-12-29
ES2530235T3 (es)	2015-02-27
US7605181B2 (en)	2009-10-20
JP2006517920A (ja)	2006-08-03
US20100087541A1 (en)	2010-04-08
CA2513092A1 (en)	2004-09-02
CN1750758A (zh)	2006-03-22
RU2521284C2 (ru)	2014-06-27
RU2008151414A (ru)	2010-06-27
ZA200504558B (en)	2010-04-28
EP1601251A4 (en)	2007-03-28
AU2008229824A1 (en)	2008-10-30
US20080015254A1 (en)	2008-01-17
EP2266946A3 (en)	2012-12-12
PL377712A1 (pl)	2006-02-06
NO334606B1 (no)	2014-04-22
IL169332A (en)	2011-04-28
IL169332A0 (en)	2007-07-04

Publication	Publication Date	Title
NO20053211D0 (no)	2005-06-30	Forbindelser for behandling av metabolske forstyrrelser.
CY2013022I1 (el)	2020-05-29	Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
NO20043237L (no)	2004-08-02	Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
NO20052223D0 (no)	2005-05-06	Tiazolforbindelser for behandling av neurodegenerative forstyrrelser
IS2722B (is)	2011-03-15	1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
IL190920A0 (en)	2009-09-22	Compounds for the treatment of metabolic disorders
IS7099A (is)	2004-01-08	Efnasambönd til að meðhöndla bólgutruflanir
NO20053041D0 (no)	2005-06-21	Behandling av diabetes.
NO20053384D0 (no)	2005-07-12	Benzazepinderivater for behandling av neurologiske forstyrrelser.
NL1029015A1 (nl)	2005-11-15	Therapeutische verbindingen.
LT2878297T (lt)	2020-07-10	Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
AP2378A (en)	2012-03-08	Sulfonamide derivatives for the treatment of diseases.
ATE410430T1 (de)	2008-10-15	2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
NO20052894D0 (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20053860D0 (no)	2005-08-18	COP 1 for behandling av inflammatorisk tarmsykdom.
AU2003286728A8 (en)	2004-06-07	Compounds for the treatment of metabolic disorders
DE602004003952D1 (de)	2007-02-08	Substituierte tetrahydrobenzothienopyrimidinamine verbindungen geeignet zur behandlung von hyper-proliferative disorders
DE502004010131D1 (de)	2009-11-05	Pyridopyrimidinone zur behandlung von krebserkrankungen
NO20045554L (no)	2004-12-20	Fremgangsmate for behandling av diabetes
GB0329874D0 (en)	2004-01-28	Compounds useful for the treatment of diseases
EP1658072A4 (en)	2009-03-25	Compounds for the Treatment of Neurodegenerative Diseases
ITMI20031311A0 (it)	2003-06-27	Formulazioni per il trattamento di disturbi artrosici
NO20055098D0 (no)	2005-11-01	Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
DE602006003094D1 (de)	2008-11-20	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DK2845594T3 (da)	2022-03-07	Anvendelse af dihydroimidazoloner til behandlingen af hunde.

Legal Events

Date	Code	Title	Description
2014-09-22	MM1K	Lapsed by not paying the annual fees